Clinical Trial Update: Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 results from a study using donor umbilical cord blood stem cell transplants in patients with hematologic malignancies have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Burkitt Lymphoma
• Chronic Myeloid Leukemia
• Diffuse Large B-cell Lymphoma
• Extranodal Nk T-cell Lymphoma Nasal Type
• Myelodysplastic Syndromes
• Waldenström Macroglobulinemia

Drugs mentioned

• Donor Umbilical Cord Blood Stem Cell Transplant (cord blood stem cell transplant)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Status: COMPLETED | Results posted: 2019-01-04